ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 Abstract F06 Josefsson, Gustaf Ames, Kerry Calizo, Milagros Schiller, Brian Groth, Kristel Ervin, Natalia Holmes, Matt Lee, Hyun Lim, Eung Ravi, Iyengar Gary Reznik Jon Liao Pharmaceuticals AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale. Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester. 2006-12 2006-12 Project deliverable application/pdf islandora:14219 http://hdl.handle.net/10560/1607 IPRO / Interprofessional Projects Program Illinois Institute of Technology en In Copyright http://rightsstatements.org/page/InC/1.0/ Open Access